Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jeffrey S. Aronin
Age : 52
Public asset : 1,586,820 USD
Linked companies : Discover Financial Services - Harmony Biosciences Holdings, Inc.
Summary 
Founder of 7 different companies, which include: OVATION Pharmaceuticals, Inc., Paragon Biosciences LLC and Emalex Biosciences, Inc. Jeffrey S. Aronin is an entrepreneur and businessperson who has been at the head of 10 different companies and occupies the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Co-Chairman of MATTER Chicago (which he founded), Non-Executive Chairman for Harmony Biosciences Holdings, Inc., Chairman & Chief Executive Officer of Paragon Biosciences LLC (which he founded in 2010), Chairman & Chief Executive Officer for Emalex Biosciences, Inc. (which he founded), Chairman for Castle Creek Biosciences, Inc. (which he founded in 2018) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Mr. Aronin is also on the board of 14 other companies.

In the past Mr. Aronin held the position of Chairman & Chief Executive Officer for Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer at Enterprise Technologies, Inc., President & Chief Executive Officer of OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer at Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

He received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.


Current positions of Jeffrey S. Aronin 
NameTitle Since
Discover Financial Services
(Banks)
Independent Director 2008
Harmony Biosciences Holdings, Inc.
(Pharmaceuticals)
Non-Executive Chairman 2017
Paragon Pharmaceuticals Capital LLC Chairman & Chief Executive Officer 2010
Emalex Biosciences, Inc. Chairman & Chief Executive Officer -
Paragon Biosciences LLC Chairman & Chief Executive Officer 2010
Castle Creek Biosciences, Inc. Chairman 2018
MATTER Chicago Co-Chairman -
CIRC Biosciences, Inc. Director -
The University of Chicago Medical Center Director -
Skyline Biosciences LLC Director -
Qlarity Imaging LLC Director -
Paragon Biosciences Qlarity Capital, Inc. Director -
Castle Creek Pharmaceutical Holdings, Inc. Director -
Paragon Biosciences Skyline Capital LLC Director & Manager -
Paragon Biosciences Emalex Capital, Inc. Director -
Harmony Biosciences LLC Director -
Castle Creek Pharmaceuticals LLC Director 2015
Ravinia Festival Association Trustee -
Pharmaceutical Research & Manufacturers of America Director 2010
The Commercial Club of Chicago Director -
The Aspen Institute, Inc. Director -


Holdings of Jeffrey S. Aronin 
NameEquities%Valuation
Discover Financial Services (DFS)
(Banks)
14,0030.0048%1,586,820 USD


Jeffrey S. Aronin: Personal Network 
Most Read News 
11/15PATRICK DRAHI : Altice founder Drahi seeks bigger stake in Britain's BT - sources
RE
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/15ELON MUSK : Analysis-Musk's $6 billion Tesla stock haul has charity circuit buzzing
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
11/17HENRIK FISKER : Fisker unveils electric SUVs to beat Tesla over driving range
RE
11/16ELON MUSK : Tesla's Musk sells another 934,000 shares to pay taxes after exercising options - filing
RE
11/15WARREN BUFFETT : Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company
RE
11/16TED ROGERS : Rogers names Staffieri interim CEO as chair stamps authority after family feud
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/15ELON MUSK : Tesla's Musk sells $930 mln in shares to cover stock option tax - filings
RE
More news


© 2021 People and Ownership :   
Jeffrey S. Aronin : Connections